
Tesamorelin
A stabilized GHRH analog investigated for endogenous GH pulse studies and lipid metabolism markers in human clinical research.
- Studied for lean tissue markers
- Investigated in visceral adipose research
- Explored for GH pulsatility
Research dosing: 1–2 mg reconstituted, subcutaneous, evening administration.
-20°C lyophilized; 2–8°C after reconstitution.
Every batch, fully traceable.
Download analytical panels and browse related documentation.
HPLC + Mass Spec assay report.
Reconstitution, storage, and shelf life.
Cited studies for this compound.
Common questions about this compound.

